U.S. to Cut Back on COVID-19 Treatments Because of Lack of Funds
The White House stated on Tuesday that the U.S. government will encounter a deficiency of provisions of COVID-19 medicines referred to as monoclonal antibodies when late in May and should make revisions to arrangements to get more except if Congress gives seriously subsidizing. Causing concern and frenzy about drained financing for the U.S. pandemic reaction, … Read more